Skip to main content
Farmacosmo logo

Farmacosmo — Investor Relations & Filings

Ticker · ZJ1 ISIN · IT0005487670 LEI · 815600ABEDB6F0BDDE28 XMIL Wholesale and retail trade
Open in API
Filings indexed 188 across all filing types
Latest filing 2023-04-07 Director's Dealing
Country IT Italy
Listing XMIL ZJ1

About Farmacosmo

https://www.farmacosmo.com/

Farmacosmo is an e-commerce company that operates an online platform for health, beauty, and personal care products. The company's core business is the online sale of a broad range of items, including parapharmaceuticals, supplements, cosmetics, personal care products, baby supplies, and pet care essentials. Managing its platform in-house, Farmacosmo offers a catalog of over 80,000 products from various brands. The company aims to provide a comprehensive wellness destination by combining the offerings of a pharmacy and a cosmetics retailer, supported by expert advice from professionals.

Recent filings

Filing Released Lang Actions
Farmacosmo - Internal Dealing - Gargiulo & Maiello
Director's Dealing Classification · 99% confidence The document is an official notification filed with Euronext Growth Milan, identified by the 'Informazione Regolamentata n.' header. The 'Oggetto' (Subject) mentions 'Internal Dealing' concerning an individual named 'Gargiulo & Maiello'. Section 2 explicitly details the 'Reason for the notification' as related to a person discharging managerial responsibilities ('Consigliere CdA' - Board Member) and their transaction. This structure perfectly matches the definition of Director's Dealing (insider trades) as defined in the provided schema. The code for this is DIRS.
2023-04-07 Italian
Farmacosmo - Internal Dealing - Var S.r.l.
Director's Dealing Classification · 99% confidence The document is a formal notification published on Euronext Growth Milan, dated April 7, 2023. The subject line ('Oggetto') explicitly mentions 'Farmacosmo - Internal Dealing - Var S.r.l.'. Furthermore, the main body title is 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' This template is used for reporting insider transactions, specifically director's dealings or transactions by closely associated persons/entities. This directly corresponds to the definition for Director's Dealing (DIRS).
2023-04-07 Italian
Farmacosmo - Internal Dealing - Var S.r.l.
Director's Dealing Classification · 99% confidence The document is an official notification ('Informazione Regolamentata') from Euronext Growth Milan concerning a transaction. The subject line explicitly mentions 'Internal Dealing' and the body contains a template titled 'Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.' This directly corresponds to the reporting requirements for insider transactions by directors or closely associated persons. This aligns perfectly with the definition for Director's Dealing (DIRS). The document is a formal regulatory filing detailing insider transactions.
2023-04-07 Italian
FARMACOSMO Avvia La Brandizzazzione Delle Prime Farmacie Fisiche
Regulatory Filings Classification · 95% confidence The document is a press release dated April 3, 2023, originating from Euronext Growth Milan, concerning the company Farmacosmo initiating the 'branding' of its first physical pharmacies as part of its omnichannel strategy. The text details business updates, strategic direction, and mentions the availability of the communication via an authorized storage mechanism ('eMarket Storage') and the company's investor relations website. The content is a general business update and strategic announcement, not a formal financial report (like 10-K or IR), a specific voting result (DVA), a management change (MANG), or a dividend notice (DIV). Since it is a formal announcement released through regulatory channels (indicated by 'Informazione Regolamentata' and 'REGEM' type), but doesn't fit the specific categories like ER, IR, or CAP, it falls best under the general regulatory announcement category, which is RNS (Regulatory Filings), as it is a formal communication disseminated via the market mechanism.
2023-04-03 Italian
FARMACOSMO: Il Consiglio Di Amministrazione Approva Il Progetto Di Bilancio E Il Bilancio Consolidato Al 31 Dicembre 2022
Earnings Release Classification · 98% confidence The document is an official communication from Farmacosmo S.p.A. dated March 31, 2023, announcing that the Board of Directors approved the draft financial statements and the consolidated financial statements for the year ended December 31, 2022. It provides key consolidated results (Revenues, EBITDA, Net Result) and discusses strategic M&A activities and operational improvements. This content strongly aligns with the release of annual financial results, which is typically covered by an Earnings Release (ER) or, given the comprehensive nature and year-end focus, potentially an Annual Report (10-K) or an Interim Report (IR) if it were quarterly. However, since it is the full year-end result announcement, and it is presented as a press release summarizing the results rather than the full statutory 10-K filing itself, the most appropriate classification among the provided options is 'Earnings Release' (ER), as it serves as the initial announcement of the full-year performance highlights. The document is substantial (over 43k characters) and contains detailed financial figures and management commentary, distinguishing it from a mere RPA or RNS. FY 2022
2023-03-31 Italian
Farmacosmo: Modifica Al Calendario Eventi Societari
Regulatory Filings Classification · 95% confidence The document is titled 'MODIFICA AL CALENDARIO EVENTI SOCIETARI 2023' (Modification to the Corporate Events Calendar 2023) and is issued as a 'COMUNICATO STAMPA' (Press Release). The core content announces a change in the date for the Board of Directors meeting to approve the draft financial statements (project of the financial statements and consolidated financial statements for the year ended December 31, 2022). It also mentions the subsequent date for the shareholders' meeting. This is a formal announcement regarding a change in the schedule of corporate events, specifically related to financial reporting deadlines. It is not the financial report itself (10-K or IR), nor is it a transcript (CT) or a general regulatory filing (RNS). Since it is an announcement about the timing/publication of corporate reports/meetings, it best fits the 'Report Publication Announcement' (RPA) category, as it modifies the schedule for the release of the annual financial results and the subsequent shareholder meeting announcement.
2023-03-30 Italian

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.